ISV President’s Message

Linda S. Klavinskis, PhD (ISV President, 2024-2025)
Professor of Viral Immunology, Department of Infectious Diseases, King’s College London.

It is an honour and privilege to serve as President of the ISV, an association that brings together talented scientists from across the globe at all stages of their careers to exchange knowledge, sparks new ideas and inspires solutions to the most challenging human, animal, and One Health problems amenable to vaccine and immunotherapeutic interventions.

I would like to thank Dr Denise Doolan, the outgoing ISV President for her leadership during her term and congratulate Ted Gibson on assuming the position of Director of ISV Operations.  Read more…

ISV Upcoming Events

Visit ISV’s YouTube Channel to access webinar recordings:

About ISV

ISV 2025  Annual Congress

ISV Events

Mentorship Programme

Next Generation Vaccinologists

ISV Membership

Donors

Sponsors

Career

ISV Newsletter

ISV Members:

Join us today:

LATEST NEWS

ISV’s Paper of the Month (POM)

April 2025

AUTHORS
Verena Lentsch, Aurore Woller  Andrea Rocker, Selma Aslani, et al.

ISV’s Paper of the Year (POY)

2024

AUTHORS
Mucker EM, Freyn AW, Bixler SL, Cizmeci D, Atyeo C, Earl PL, Natarajan H, Santos G, Frey TR, Levin RH, Meni A, Arunkumar GA, Stadlbauer D, Jorquera PA, Bennett H, Johnson JC, Hardcastle K, Americo JL, Cotter CA, Koehler JW, Davis CI, Shamblin JD, Ostrowski K, Raymond JL, Ricks KM, Carfi A, Yu WH, Sullivan NJ, Moss B, Alter G, Hooper JW.

ISV NextGen May Webinar

Thursday, May 8th

Topic 1:Delivering Pandemic Vaccines in 100 Days — What Will It Take?, Dr Renske Hesselink, CEPI

Topic 2: Advancing saRNA Delivery: Evaluating Novel PEI-Inspired Polymers as Non-Viral Carriers, Lisa Opsomer, PhD student, Ghent University


More info…

ISV Webinar Series

Wednesday, May 28th

Title: Computational Modelling of Vaccine Responses

Speaker: Tal Einav, LaJolla Institute of Immunology, United States


More info…

ISV Annual Supporters

The International Society for Vaccines is an organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines and immunotherapeutics.  The ISV is a global not-for-profit organization that aims to encourage, establish, and promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.
info@isv-online.org  /  ISV Annual Congress